Ana Galán‐Cobo
机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-0988-1823
发表论文 93 篇 · 总被引 2766 次 · h-index 14
代表论文
- CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2024 · Nature · 被引 171)
- KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer (2025 · Cancer Cell · 被引 20)
- High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas (2025 · Cancers · 被引 2)
- Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2025 · Nature · 被引 1)
- Clinical Impact of Mismatch Repair Gene Mutation–Based Alert on Immunotherapy Decision Making Across Patients With Cancer (2026 · JCO Clinical Cancer Informatics)
- Analytical Validation of a Plasma-Based Rapid Liquid Biopsy Assay Using Next-Generation Sequencing (2026 · Journal of Molecular Diagnostics)